statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-B21 trial evaluating KEYTRUDA, Mercks anti-PD-1 therapy, in combination with...

Merck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intent

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Caroline Litchfield, executive vice president and chief financial officer, is scheduled to participate in...

Merck to Participate in the Bank of America Securities 2024 Healthcare Conference

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-811 trial evaluating KEYTRUDA (pembrolizumab), Mercks anti-PD-1 therapy, in...

Merck Announces Phase 3 KEYNOTE-811 Trial Met Dual Primary Endpoint of Overall Survival (OS) as First-Line Treatment in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from STRIDE-10, a Phase 3 trial evaluating V116, the companys investigational, adult-specific...

Merck Announces Positive Data for V116, an Investigational, 21-Valent Pneumococcal Conjugate Vaccine Specifically Designed for Adults

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2024. Merck has begun 2024 with continuing momentum in our business...

Merck Announces First-Quarter 2024 Financial Results

Dividends can provide a steady stream of income to shareholders, but only if the dividend-paying company maintains or increases its payouts over the years. Unfortunately, not every dividend payer is...

2 Dividend Stocks to Buy and Hold Forever

GFS Advisors LLC grew its position in shares of Merck  Co., Inc. (NYSE:MRK - Free Report) by 0.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange...

Merck & Co., Inc. (NYSE:MRK) Shares Bought by GFS Advisors LLC

Murphy Middleton Hinkle  Parker Inc. lessened its holdings in Merck  Co., Inc. (NYSE:MRK - Free Report) by 2.2% in the 4th quarter, according to the company in its most recent 13F filing...

Murphy Middleton Hinkle & Parker Inc. Lowers Stake in Merck & Co., Inc. (NYSE:MRK)

Sowell Financial Services LLC grew its stake in Merck  Co., Inc. (NYSE:MRK - Free Report) by 2.4% during the fourth quarter, according to the company in its most recent disclosure with the...

Merck & Co., Inc. (NYSE:MRK) Shares Acquired by Sowell Financial Services LLC

QV Investors Inc. cut its holdings in Merck  Co., Inc. (NYSE:MRK - Free Report) by 2.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 41,552 shares of the company's stock after...

QV Investors Inc. Sells 1,160 Shares of Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Watchers	22,173
52-Wk Low	$99.14
52-Wk High	$133.10

Volume	5.72M
52-Wk High	$133.10
52-Wk Low	$99.14

Period	Estimated	Reported	Surprise	Result
Q2'24	$2.13	--	--	N/A
Q1'24	$1.90	$2.07	9.07%	BEAT
Q4'23	-$0.11	$0.03	127.66%	BEAT
Q3'23	$1.95	$2.13	9.04%	BEAT
Q2'23	-$2.18	-$2.06	5.53%	BEAT

MRK Merck & Co Inc

About

Feed

News

Sentiment

Earnings

Fundamentals